InsidersTradesSigma
Follow the 塩野義製薬株式会社 share price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on the JP market, under the oversight of EDINET (Japan FSA). Operating in the Banks sector, 塩野義製薬株式会社 has logged 6 insider filings. Market capitalisation: €40,416.3bn. The latest transaction was reported on 19 September 2025 (Holding update). Among the most active insiders: Sumitomo Mitsui Trust Bank,Limited. Every trade is free.
Analysts rate 塩野義製薬株式会社 Buy (bullish), based on 11 analysts. Average price target: JP¥3,596.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
6 of 6 declarations
Shionogi & Co., Ltd. es una empresa farmacéutica japonesa centrada en la investigación y el desarrollo de medicamentos. Cotiza en la Bolsa de Tokio bajo el símbolo XTKS.